any anitplatelet drug, mainly aspirin (95% of included patients)
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2017 07 29;390(10093):490-499 Cohorts
IN antiplatelet drugs, aspirin, bleeding risk The Use of
any anitplatelet drug, mainly aspirin (95% of included patients)
As Treatment, Chronic
Is worse Than
no antipaltelet therapy
To increase the risk of bleeding. Bleeding rate increased with age from 70 years on, specially major and life-threatening bleeding. Localizations, by frequency: gastrointestinal, genitourinary, intracranial, epistaxis, others